REGISTERED
on 30 Nov 2021
Last Applicant/ Owned by
I-20122 MILANO
IT
Serial Number
79297326 filed on 29th Sep 2020
Registration Number
6571369 registered on 30th Nov 2021
Correspondent Address
Caleb Norris
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
DOLTENDIX
Pharmaceuticals and pharmaceutical preparations for treating osteoarticular diseases; dietary, nutritional, mineral, dietary nutraceutical, and vitamin supplements and preparations for medical purposes; dietary enzyme and protein supplements; dietetic food and preparations adapted for medical purposes; all the aforesaid goods for use in the osteoarticular field
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals and pharmaceutical preparations for treating osteoarticular diseases; dietary, nutritional, mineral, dietary nutraceutical, and vitamin supplements and preparations for medical purposes; dietary enzyme and protein supplements; dietetic food and preparations adapted for medical purposes; all the aforesaid goods for use in the osteoarticular field
Mark Details
Serial Number
No 79297326
Mark Type
No Service/Collective Mark
Attorney Docket Number
No HE1 0052 US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
02.11.08 -
Feet, toes, imprints of feet or toes, legs
26.15.21 -
Polygons that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Mar 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| 12th Jun 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 21st May 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| 20th May 2022 | FINAL DISPOSITION PROCESSED |
| 29th Apr 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| 28th Feb 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 30th Nov 2021 | REGISTERED-PRINCIPAL REGISTER |
| 14th Sep 2021 | PUBLISHED FOR OPPOSITION |
| 14th Sep 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 26th Aug 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |